Cite
HARVARD Citation
Dilla, T. et al. (2017). The cost-effectiveness of dulaglutide versus liraglutide for the treatment of type 2 diabetes mellitus in Spain in patients with BMI ≥30 kg/m2. Journal of medical economics. pp. 443-452. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dilla, T. et al. (2017). The cost-effectiveness of dulaglutide versus liraglutide for the treatment of type 2 diabetes mellitus in Spain in patients with BMI ≥30 kg/m2. Journal of medical economics. pp. 443-452. [Online].